J&J Seeks To Reclaim Schering's Arthritis Drug Rights
Johnson & Johnson has filed a demand for arbitration to sever an agreement between a subsidiary and Schering-Plough Corp. over the full rights to market and sell arthritis treatments Remicade and...To view the full article, register now.
Already a subscriber? Click here to view full article